Navigation Links
Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
Date:9/12/2007

information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Other Information

In August, Ms. Karen Terrick joined Sunesis as a Director, Regulatory Affairs. In conjunction with her joining, the Compensation Committee of the company's Board of Directors approved an employment commencement grant to Ms. Terrick of a non-qualified stock option to purchase 25,000 shares of Sunesis common stock, effective August 31, 2007. This option award was granted without shareholder approval pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv) and with the following material terms: (a) an exercise price equal to the fair market value of the company's common stock on the grant date, (b) a term of ten years, and (c) a vesting schedule providing that the option is exercisable as to one-quarter of the total grant on the first anniversary of Ms. Terrick's hire, and one-forty-eighth of the total grant each month thereafter until the grant is fully vested.

Safe Harbor Statement

This press release contains forward-looking statements, including without limitation statements related to the safety, tolerability and potential efficacy of SNS-595 (alone and in combination with cytarabine) and SNS-314, planned clinical testing and development efforts and the anticipated clinical sites and timing of clinical trials. Words such as "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, Sunesis' drug discovery, development and clinical manufacturing activities could be halted or significantly delayed, Sunesis' clinical trials for SNS-59
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
3. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
4. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
5. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Creekridge Capital, an independent vendor-focused finance company, ... far in 2014 to their portfolio of contractual ... both the healthcare and technology industries. They range ... companies. Each of these new vendors take advantage ... standard leasing products, subscription solutions, a dedicated revolving ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- Top Staten Island Pediatrician ... feedback on article, which discusses tips for parents about pool ... According to US News article, ... among American children aged 1 to 4, and can occur ... One expert in the article says that watching a child ...
(Date:7/23/2014)... 2014  Nonin Medical, Inc., the inventor of finger ... announced today that Mark VanderWerf , Nonin,s Vice ... of the American Telemedicine Association,s (ATA) Industry Council and ... The ATA is the leading international resource and advocate ... ATA and its diverse membership work to transform healthcare ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2
... leukemia relapse cases arise from a cell already present at ... MEMPHIS, Tenn., Nov. 27 Scientists at St. Jude ... cancer cells of children with acute lymphoblastic leukemia (ALL) that ... for ALL relapse in children and, ultimately, in adults. , ...
... awareness can improve recovery , , ... on the Mayo Clinic News Blog. Please see the bottom of ... , ROCHESTER, Minn., Nov. 25 A Mayo ... having a stroke -- and as a result -- delay seeking ...
Cached Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3
(Date:7/23/2014)... The European Bio fertilizers Market Report defines ... analysis and forecast of revenue. The bio fertilizers market ... 2,566.4 million in 2012 to $4,582.2 million by 2017, ... , Browse through the TOC of the European Bio ... in-depth analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , ...
(Date:7/23/2014)... Texas (PRWEB) July 23, 2014 ... 2020?, provides key market data on the North ... value, in millions of US dollars, and volume ... dollars), within market categories Cardiac Valve Repairs and ... shares and distribution shares data for each of ...
(Date:7/23/2014)... "I wanted a better way to keep ... blood sugar, blood pressure and pulse rate," said an inventor ... to carry along a bunch of different devices, so I ... the Master III to make it easier to monitor health ... unit. The accessory enables the user to have more control ...
(Date:7/23/2014)... to consider innovative methods to prevent fatigue from developing ... a new study published in the Journal of ... who are obese may have significantly shorter endurance times ... , The study, conducted at Virginia Tech in ... four categories (non-obese young, obese young, non-obese older, and ...
(Date:7/23/2014)... 2014) Statins, a class of drugs commonly used ... of developing Barrett,s esophagus, according to a new study ... official journal of the American Gastroenterological Association. Obese patients ... use. , "Patients who received statins had a 43 ... compared to non-users," said study author Hashem B. El-Serag, ...
Breaking Medicine News(10 mins):Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Obesity linked to low endurance, increased fatigue in the workplace 2Health News:Statin use decreases the risk of Barrett's esophagus 2
... Gwyneth Paltrow, Shakira, Courtney Cox and Kate Hudson, will be hosting ... to the public. Finally sharing her long awaited Nutritional Meal ... Food Cleanse and Lifestyle Menu. She will also be teaching ... muscle structure work. Both events are open to the public. ...
... ... of Genes , ... (Vocus) November 9, 2009 -- Understanding patients’ ancestries can be extraordinarily valuable when analyzing ... genomes of 4,000 people throughout Europe and found clear regional differences, Drs. Chao Tian ...
... differences in mood despite similar weight loss , MONDAY, Nov. 9 ... popular Atkins program and a low-fat, high-carb diet appear to help ... But as for mood? Only the low-fat diets will result in ... 9 issue of Archives of Internal Medicine . , People ...
... ... poll by Fitness.com.au however finds that 80% of people think that parents should shoulder the ... (PRWEB) November 9, ... epidemic, think again. Mum and Dad are more than just innocent bystanders. A recent ...
... has posted a draft white paper for public ... comparative effectiveness clinical evaluations based upon existing data. ... (CTI), a consensus-based process that compares the risk-versus-benefit ... Clinical Practice Guidelines in Oncology(TM). The paper will ...
... to providing long-term healthcare institutions with advanced entertainment and ... latest Long-Term Care and Hospital Grade LCD HDTVs this ... the Aging 2009 annual meeting and exposition (booth #1760). ... of "HealthView(TM)" Long-Term Care LCD HDTVs bring a sense ...
Cached Medicine News:Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:News from the November/December Issue of Molecular Medicine 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
Volume: 5 ml; Volume Graduation: 1/10 ml...
... Pipette Aid, which is for use with measuring ... comfortably with precision. It works with all types ... range from 1 mL to 100 mL.Gilsons Pipette ... replaceable membrane filters, which protect the mechanism of ...
Application: Safe and convenient filling and dispensing of glass and plastic pipets....
Trio is a portable pipette stand that keeps your Gilson pipettes within easy reach. A great accessory for use in a fume hood....
Medicine Products: